Roche, GSK cancer pill combos look similar in showdown

September 29, 2014 8:13 AM

14 0

MADRID, Sept 29 (Reuters) - Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline have yielded similar results in separate clinical trials, leaving doctors with little to choose between the two regimens.

Roche's combination is not yet available but GSK is already marketing its combined treatment, though it now plans to sell the drugs involved and other oncology products to Novartis under a deal announced in April.

Read more

To category page